#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Acute myeloid leukaemia Wolfram syndrome Non-renal cell carcinoma of kidney Infection in an immunocompromised host Neoplasm malignant Skin angiosarcoma Myelodysplastic syndrome Haemophagocytic lymphohistiocytosis Hypochondroplasia Non-small cell lung cancer Synovial sarcoma metastatic Arteriosclerosis Gastrooesophageal cancer Granulomatosis with polyangiitis Allogenic stem cell transplantation More trials…

Learn about Rare Diseases

Congenital hypotransferrinaemia – Trials in Disease Systemic mastocytosis – Basic Information Rosai-Dorfman syndrome – Trials in Disease Waldenstrom’s macroglobulinaemia refractory Angelman’s syndrome – Basic Information Systemic mastocytosis – Life with Disease Alagille syndrome – Life with Disease Pulmonary sarcoidosis – Basic Information Nephrotic syndrome – Trials in Disease Factor VIII deficiency – Treatment More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

Atidarsagene Autotemcel Human Coagulation Factor Vii Charcoal, Activated Ertapenem Allopurinol Sodium Tin816 Giroctocogene Fitelparvovec Tenecteplase Bi 1291583 Rozanolixizumab ARGININE GLUTAMATE Osilodrostat Urapidil Niflumic Acid Diltiazem Hydrochloride Emibetuzumab Losartan HUPERZINE A Briquilimab Tecaginlimab More therapies…

Learn about Your Condition

Obsessive-compulsive disorder Toxic epidermal necrolysis Ataxia telangiectasia Stomatitis Metastases to meninges Hyperparathyroidism secondary Heparin resistance Sarcoma metastatic Mitochondrial myopathy Contusion Anal cancer Endocarditis Liposarcoma recurrent Vaginal cancer Hereditary ataxia More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe

🇦🇹 Austria

🇭🇷 Croatia

🇨🇿 Czech Republic

🇩🇰 Denmark

🇪🇪 Estonia

🇫🇮 Finland

🇫🇷 France

🇩🇪 Germany

🇮🇸 Iceland

🇮🇹 Italy

🇱🇻 Latvia

🇱🇹 Lithuania

🇳🇱 Netherlands

🇳🇴 Norway

🇵🇱 Poland

🇵🇹 Portugal

🇷🇴 Romania

🇸🇰 Slovakia

🇸🇮 Slovenia

🇪🇸 Spain

🇸🇪 Sweden

Idiopathic inflammatory myopathy

Phase 2 Study of Daxdilimab with Prednisone in Adults with Inadequately Controlled Dermatomyositis or Anti‑Synthetase Inflammatory Myositis

Not recruiting

2 1 1
Investigated Diseases:
Investigated Drugs:
- Daxdilimab
- Prednisone
Study on the Effects and Safety of Efgartigimod PH20 SC for Adults with Active Idiopathic Inflammatory Myopathy

Not recruiting

4 1
Investigated Diseases:
- Idiopathic inflammatory myopathy
Investigated Drugs:
- Efgartigimod Alfa
+13
Study of intravenous immunoglobulin combined with prednisone compared to prednisone alone in newly diagnosed patients with inflammatory myositis

Not recruiting

2 1 1
Investigated Drugs:
- Human Normal Immunoglobulin
- Sodium Chloride

1 2

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Idiopathic inflammatory myopathy

Phase 2 Study of Daxdilimab with Prednisone in Adults with Inadequately Controlled Dermatomyositis or Anti‑Synthetase Inflammatory Myositis

Study on the Effects and Safety of Efgartigimod PH20 SC for Adults with Active Idiopathic Inflammatory Myopathy

Study of intravenous immunoglobulin combined with prednisone compared to prednisone alone in newly diagnosed patients with inflammatory myositis

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies